ClinicalTrials.gov
public full text
Public Domain
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
The purpose of this study is to evaluate the efficacy of each individual dose of esketamine nasal spray, 56 milligram (mg) and 84 mg, compared with placebo nasal spray in improving depressive symptoms in participants with treatment resistant depression (TRD), as assessed by the change from baseline in the Montgomery-Asberg Depression Rating Scale (MADRS) total score from Day 1 (prerandomization) to the end of the 4 week double-blind treatment phase (Day 28).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cost-effectiveness of esketamine versus alternative treatment strategies for treatment-resistant depression in Hong Kong: A multi-armed modeling study.#140786
- Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study / Andreas Reif, A. Elif Anıl Yağcıoğlu, István Bitter, Jozefien Buyze, Richard Frey, Dong-Jing Fu, Yordan Godinov, Lars Häggström, Yerkebulan Kambarov, René Ernst Nielsen, Albino Jorge Oliveira-Maia, Christian von Holt, Allan H. Young, Wiesław J. Cubała#1078728
- ECHO: Study design and baseline characteristics of a non-interventional cohort study of esketamine nasal spray in treatment resistant depression / Eric Constant, Christine Reif-Leonhard, Ángela Ibañez, Lars Häggström, Yordan Godinov, Benoît Rive, Christian von Holt, Yerkebulan Kambarov, Gianluca Rosso ; ECNP Congress (38. : 2025 : Amsterdam)#1078729
- Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects#257428
- Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI)#813660
Record · ID 874283
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive